drugset

drugset / Trial / NCT00236197

E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers

NCT00236197 ↗

Phase 3 Completed 619 enrolled Eisai Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the safety and efficacy of rabeprazole 10 mg in treating frequent heartburn.

Timeline

Start: 2005-10
Primary completion: 2006-03
Completion: 2008-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rabeprazole	Small molecule	10 mg	Oral

Indications